Several characteristics associated with an increased likelihood of a pathogenic BRCA1 or BRCA2 variant include young age of breast cancer onset (<45 years), epithelial ovarian cancer, triple negative breast cancer, or multiple relatives with breast and/or ovarian cancer. This evidence concerns the gene BRCA2 and ovarian carcinoma.